Parkinsonian Disorders: all 218 studies

Page 1 of 3. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.

• Strength and Dual-Task on Sarcopenia in People With Parkinson's DiseaseRecruitingNCT07907302Not applicable
• VisMemoPD Protocol: an Observational Pilot Study on Spatial and Topographical Memory in Patients With Parkinson's Disease and ParkinsonismNot yet recruitingNCT07827963
• A Trial of ONO-2808 in Participants With the Parkinsonian Subtype of Multiple System Atrophy (MSA-P)Not yet recruitingNCT07825402Phase 3
• A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapyRecruitingNCT07804615Phase 2
• Young Onset Parkinson's Disease Subtypes and Pathogenic MechanismsRecruitingNCT07752355
• ZR001 Chemogenetics Gene Therapy Study in Patients With Parkinson's DiseaseNot yet recruitingNCT07718659Phase 1
• Temporal Interference Noninvasive Deep Brain Stimulation for Idiopathic Parkinson's Disease and Parkinsonian Syndromes: Effects and Target ExplorationEnrolling by invitationNCT07698236Not applicable
• Monoamine Oxidase B PET/CT in Various MAO-B-Related DiseaseRecruitingNCT07685873
• Cross-System Effects of Acute Intermittent Hypercapnia-Based Interventions in PDRecruitingNCT07674264Not applicable
• Sensing in Sleep Deep Brain StimulationRecruitingNCT07636720Not applicable
• Individualized Transcranial Magnetic Stimulation in Parkinsonian DisordersRecruitingNCT07570212Not applicable
• A Multimodal Prospective Cohort Study of ParkinsonismRecruitingNCT07553845
• Ultralow Dose PET Imaging of 18F-FDOPAEnrolling by invitationNCT07542158Phase 2
• DaxibotulinumtoxinA for BlepharospasmRecruitingNCT07489430Phase 2
• Evaluation of Neuroinduced Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Exosomes in Patients With ParkinsonismNot yet recruitingNCT07471230Phase 2
• Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)RecruitingNCT07386015
• Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical ActivityRecruitingNCT07324330Not applicable
• The Effect of Spinal Cord Stimulation on Orthostatic Hypotension in Parkinsonism and Its Related MechanismsNot yet recruitingNCT07322458Not applicable
• AAV2-hAADC for Parkinson's Disease (PDCS-01)Not yet recruitingNCT07267065Phase 1
• Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.RecruitingNCT07207096
• Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's DiagnosisRecruitingNCT07204652
• Study of Axial and Cognitive Symptoms and Biomarkers of Neurodegeneration in Brain-first and Body-first PDRecruitingNCT07187843
• Clinical Efficacy of Intermittent Theta Burst Transcranial Magnetic Stimulation With Different Modes on Parkinson's DiseaseEnrolling by invitationNCT07176091Not applicable
• Clinical Efficacy and Mechanism of tDCS for Dysphagia in PDRecruitingNCT07153692Not applicable
• Slow-SPEED: Slowing Parkinson's Early Through Exercise DosageRecruitingNCT06993142Not applicable
• Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PDRecruitingNCT06914466
• An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman SpectroscopyEnrolling by invitationNCT06875739
• Saliva and Extracellular Vesicles for Neurodegenerative DiseasesRecruitingNCT06869135
• Clinical Study of Rhythmic Auditory Stimulation for Gait DisordersEnrolling by invitationNCT06837038Not applicable
• The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's DiseaseRecruitingNCT06608355Phase 1
• Behavioral Intervention for Lifestyle Physical Activity in Parkinson's DiseaseNot yet recruitingNCT06603012Not applicable
• Blood Flow Restriction for Optimizing Balance in Parkinson's DiseaseRecruitingNCT06508801Not applicable
• Pesticides and Parkinson´s DiseaseRecruitingNCT06420310
• Mechanism and Application of DBS in the Treatment of PDRecruitingNCT06400017Not applicable
• Personalized rTMS Protocol Based on Functional Reserve to Enhance Ambulatory Function in PD PatientsRecruitingNCT06350617Not applicable
• Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's DiseaseEnrolling by invitationNCT06283043
• NYSCF Scientific Discovery BiobankRecruitingNCT06203106
• Individual Neuromodulation for PDSRecruitingNCT06193278Not applicable
• Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-NetherlandsRecruitingNCT06193252Not applicable
• The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related DisordersRecruitingNCT06174948Not applicable
• Contribution of the Kinematic Theory in the Early Differential Diagnosis of the Parkinson's DiseaseRecruitingNCT06161636
• [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD Vs. MSA and DLB Vs. ADRecruitingNCT06120049Phase 2/3
• Effect of Adding Computerized Cognitive Training on Balance, Locomotion and Cognition in Parkinson's DiseaseRecruitingNCT06104072Not applicable
• Caregiving in Advanced PD: A Tailored Support GroupNot yet recruitingNCT06074393Not applicable
• A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's DiseaseRecruitingNCT05965661Not applicable
• Sleep-specific DBS Therapy in Parkinson's DiseaseRecruitingNCT05962489Not applicable
• Aim 3 Particle Swarm Optimization PIGDRecruitingNCT05934747Not applicable
• Virtual Reality and Fear of Falling in Parkinson's DiseaseRecruitingNCT05931692
• Continued Evaluation of Patients With Parkinson's Disease Who Previously Received BRT-DA01Enrolling by invitationNCT05897957
• Ultrasound Changes of the Vagus Nerve in Patients With ParkinsonismRecruitingNCT05834634
• Ambroxol to Slow Progression in Parkinson DiseaseRecruitingNCT05778617Phase 3
• Prodromal and Overt Parkinson's Disease Epidemiological Study in BrazilRecruitingNCT05677529
• MIBG in Aging and Neurologic DisordersEnrolling by invitationNCT05514106Phase 4
• Efficacy and Safety of Astragalus for Non-motor Symptoms of α-SynucleinopathyRecruitingNCT05506891Phase 2
• Spinal Cord Stimulation for ParkinsonismRecruitingNCT05171205Not applicable
• Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsRecruitingNCT04782830Not applicable
• Digitally-enhanced, Decentralized, Multi-omics Observational CohortEnrolling by invitationNCT04701177
• The National Registry Study For the Real-world Patients With Parkinsonian Disorders in ChinaRecruitingNCT03649503
• Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as CorrelatesRecruitingNCT03495024Phase 4
• Parkinson's Families ProjectRecruitingNCT02760108
• Modifiable Variables in Parkinsonism (MVP)RecruitingNCT02194816
• Biomarkers in Parkinsonian SyndromesRecruitingNCT02114242
• DaTSCAN Imaging in Aging and Neurodegenerative DiseaseEnrolling by invitationNCT01453127Phase 4
• Altropane Dose for Imaging Patients With Suspected Parkinson's DiseaseTerminatedNCT05636852Phase 2Results posted
• Immersive Virtual Reality Bicycling for Persons With Parkinson's DiseaseCompletedNCT05160025Not applicableResults posted
• STEM-PD Open Label Extension (OLE)TerminatedNCT04799418Not applicableResults posted
• STEM-Parkinson's DiseaseCompletedNCT04797611Not applicableResults posted
• Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)CompletedNCT04542499Phase 3Results posted
• Flexible-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04223193Phase 3Results posted
• Fixed-Dose Trial in Early Parkinson's Disease (PD)CompletedNCT04201093Phase 3Results posted
• A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese PatientsCompletedNCT04193527Phase 3Results posted
• Effects of Exercise on Glymphatic Functioning and Neurobehavioral Correlates in Parkinson's DiseaseCompletedNCT04140708Not applicableResults posted
• Study of UB-312 in Healthy Participants and Parkinson's Disease PatientsCompletedNCT04075318Phase 1Results posted
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureTerminatedNCT03829657Phase 3Results posted
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureCompletedNCT03750552Phase 3Results posted
• Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral RopiniroleTerminatedNCT03250117Phase 1/2Results posted
• Parkinson Disease and DBS: Cognitive Effects in GBA Mutation CarriersCompletedNCT03234478Results posted
• Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced DyskinesiaCompletedNCT02274766Phase 3Results posted
• Open-Label Safety Study of ADS-5102 in PD Patients With LIDCompletedNCT02202551Phase 3Results posted
• Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.TerminatedNCT02153645Phase 3Results posted
• Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LIDTerminatedNCT02153632Phase 3Results posted
• ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)CompletedNCT02136914Phase 3Results posted
• Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)CompletedNCT01397422Phase 2/3Results posted
• Usefulness of α-synuclein as a Marker for Early Diagnosis of Parkinson's Disease in Skin Biopsy.CompletedNCT01380899Results posted
• Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and ParkinsonismTerminatedNCT00745030Not applicableResults posted
• Study of Preladenant for the Treatment of Antipsychotic Induced Movement Disorders in Participants With Schizophrenia (Study P04628)TerminatedNCT00686699Phase 2Results posted
• A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar SymptomsCompletedNCT00382967Phase 4Results posted
• Exploration of the Association Between White Matter Lesion Burden and Dalfampridine Response in Insidious-Onset Vascular ParkinsonismCompletedNCT07682428
• Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in the GBA1 Gene (GBA-PD) and Completed the ACTIVATE StudyNo longer availableNCT07522606
• Context- and Terrain-aware Gait AnalysisWithdrawnNCT07491588
• The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease PatientsCompletedNCT07442370Not applicable
• Seated Tai Chi Improves Dynamic Finger Pointing Task and Sitting Balance Control in Subjects With Parkinson's DiseaseCompletedNCT06928532Not applicable
• Biomarkers in Parkinsonian SyndromesActive, not recruitingNCT06501469
• High-frequency Alternating Current Stimulation for Tremor in Parkinson's Disease.CompletedNCT06247423Not applicable
• A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®CompletedNCT06037590Phase 1
• Voice-activated Intelligent Personal Assistant (VIPA) Intervention for People With Parkinson's DiseaseCompletedNCT06036771Not applicable
• TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish PopulationCompletedNCT06032585
• Telerehabilitation for Dysautonomia in Parkinson's DiseaseCompletedNCT06017232Not applicable
• Advance Care Planning and Care Coordination for People With Parkinson's DiseaseCompletedNCT05954013Not applicable
• Machine Vision Based MDS-UPDRS III Machine RatingCompletedNCT05906719

← Parkinsonian Disorders overview